openPR Logo
Press release

Companion Diagnostics Market Value Chain and Forecast 2016-2026

12-19-2016 02:00 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Companion Diagnostics Market Value Chain and Forecast

Companion diagnostics are tests to understand which patient can be benefited from a certain drug or what dosage should be prescribed based upon patient’s clinical diagnosis, which provides evidence required for the successful and harmless use of an equivalent drug or biological product to treat the medical condition. These are medical instruments that support doctors to elect which treatment and dosage should be given to patients personalized to their necessity.

Companion Diagnostics is utilized to ascertain who would benefit from treatment and it comes in handy to identify if someone cannot be cured, but also conversely can be harmed by use of specific drug used for their ailment. Technological advancements has brought a lot of changes in the method of disease treatment. Companion diagnostics is characterized by growing requirement for enhancedpersonalized patient treatment that gives healthcare providers and their patients an assurance about the treatment result in a positive way, contrary to traditional treatment procedure. Major impact of companion diagnostic will been on oncology therapy area.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1255

Companion Diagnostics Market: Drivers and Restraints

Presently, companion diagnostics global market is driven by the technological advancement in healthcare industry, increase in various treatment procedures. Number of companion diagnostics can be given approval for a single drug as scientific knowledge advances with practical application of treatment. Although, cost related with latest technology acts as a key barrier for the growth of global companion diagnostics market.

Companion Diagnostics Market: Segmentation

Companion diagnostic global market is segmented into following segments:

By Application

Colorectal Cancer

Breast Cancer

Lung Cancer

Melanoma

Urology

Gastric Cancer

By Technology

Immunohistochemistry

Molecular Diagnostics

In-situ Hybridization

FISH

CISH

Real Time PCR

Gene Sequencing

By Region

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa, N. Africa)

Companion Diagnostics Market: Overview

With rapid technological advancement, increase in the incidence of chronic disease, rise in aging population, increasing adoption rate of treatment of chronic disease, increase in number of prevalence of chronic disease around the globe are the factors expected to boost the companion diagnostics market over the forecast period.

Companion Diagnostics Market: Region-wise Outlook

Depending on geographic regions, global companion diagnostics market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa.

North America is the leading market for companion diagnostics because of rapid technical inventions, huge investment on research and development in this region. Whereas, Asia-Pacificand Europeis projected to grow at a significant growth due to large consumer base, rising government initiatives for enhancing healthcare infrastructure, and high disposable income.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1255

Companion Diagnostics Market: Key Players

Some of the key participating global players in companion diagnostics market global market are ARUP Laboratories, Roche Molecular Systems Inc., Dako Inc., Qiagen Ltd., bioMérieux Inc.,Ventana Medical Systems Inc., Abbott Molecular Inc., Myriad Genetics Inc.,Biogenex Laboratories, Inc., Thermo Fisher Scientific Inc., Leica Biosystems Nussloch GmbH and others.

About Us – Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

Contact Us:
Future Market Insights
616 Corporate Way,
Suite 2-9018,
Valley Cottage,
New York 10989,
United States
Tel: +1-347-918-3531
Fax: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics Market Value Chain and Forecast 2016-2026 here

News-ID: 398028 • Views:

More Releases from Future Market Insights

European Nonwoven Air Conditioning Filter Market Outlook 2025-2035: Key Developments and Future Scope
European Nonwoven Air Conditioning Filter Market Outlook 2025-2035: Key Developm …
The global Nonwoven Air Conditioning Filter Market is set for a decade of robust expansion, rising from USD 1.1 billion in 2025 to USD 2.0 billion by 2035, according to new data-driven industry analysis. Registering a stable CAGR of 6.0%, the market's long-term outlook remains strong as clean-air technologies, regulatory standards, and health-focused infrastructure upgrades shape the future of HVAC filtration across developed and emerging economies. Growing emphasis on indoor air
European Scouring Pads Market Outlook 2025-2035: Key Developments and Future Scope
European Scouring Pads Market Outlook 2025-2035: Key Developments and Future Sco …
The global Scouring Pads Market is positioned for robust expansion over the next decade, supported by rising hygiene awareness across households, commercial kitchens, and industrial cleaning environments. Valued at USD 5.0 billion in 2025, the market is forecast to reach USD 8.3 billion by 2035, advancing at a CAGR of 5.2%. Growth strengthens significantly in the latter half of the forecast period, with 73% of total expansion occurring between 2030
European Reinforced Nonwoven Plastics Market Outlook 2025-2035: Key Developments and Future Scope
European Reinforced Nonwoven Plastics Market Outlook 2025-2035: Key Developments …
The global Reinforced Nonwoven Plastics Market is entering a pivotal growth cycle, with new data indicating a strong expansion trajectory across major regions-APAC, Europe, the USA, and Saudi Arabia. Driven by rising demand in automotive, construction, filtration, hygiene, and packaging applications, the market is projected to reach USD 6.8 billion by 2035, advancing at a healthy CAGR supported by technological innovation, sustainability mandates, and increasing industrial infrastructure investments. The sector, which
European Nonwoven Sponges Market Outlook 2025-2035: Key Developments and Future Scope
European Nonwoven Sponges Market Outlook 2025-2035: Key Developments and Future …
The global Nonwoven Sponges Market is entering a decade of robust and sustained expansion, driven by rising healthcare demand, strict infection control standards, and rapid adoption across clinical, personal care, and industrial cleaning applications. The market is valued at USD 750 million in 2025 and is projected to reach USD 1.318 billion by 2035, registering a healthy CAGR of 5.8% over the forecast period. The growth trajectory is marked by two

All 5 Releases


More Releases for Companion

Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in …
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlook
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy …
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors. The Artificial Intelligence (AI) In Beauty and Cosmetics Market
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani …
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673 This latest report researches the industry structure, sales, revenue,
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test